TY - JOUR
T1 - Prevalence and determinants of cervical cancer screening in five sub-Saharan African countries
T2 - A population-based study
AU - Ba, Djibril M.
AU - Ssentongo, Paddy
AU - Musa, Jonah
AU - Agbese, Edeanya
AU - Diakite, Brehima
AU - Traore, Cheick Bougadari
AU - Wang, Steve
AU - Maiga, Mamoudou
N1 - Funding Information:
JM received funding through an International Research Career Development Award from the NIH/FIC (grant #K43TW011416 ) that provided research-protected time for reviewing and writing of this manuscript. PS was aslo supported by the NIH Director’s Transformative Award 1R01AI145057 . The funding agencies cited here did not play a role in the design, collection of data, analysis, interpretation, and writing of this manuscript or decision to publish the results. The contents of this manuscript are solely the responsibility of the authors and do not necessarily represent the official views of NIH/Fogarty International Center.
Publisher Copyright:
© 2021 Elsevier Ltd
PY - 2021/6
Y1 - 2021/6
N2 - Background: Cervical cancer is the fourth most common cancer among women worldwide, with an estimate of 570,000 new cases and about 311,000 deaths annually. Low-resource countries, including those in sub-Saharan Africa, have the highest-burden with an estimate of 84 % of all cervical cancers. This study examines the prevalence and socio-demographic-economic factors associated with cervical cancer screening in sub-Saharan Africa. Methods: A weighted population-based cross-sectional study using Demographic and Health Surveys data. We used available data on cervical cancer screening between 2011 and 2018 from the Demographic and Health Surveys for five sub-Saharan African countries (Benin, Ivory Coast, Kenya, Namibia, and Zimbabwe). The study population included women of childbearing age, 21–49 years (n = 28,976). We fit a multivariable Poisson regression model to identify independent factors associated with cervical cancer screening. Results: The overall weighted prevalence of cervical cancer screening was 19.0 % (95 % CI: 18.5 %–19.5 %) ranging from 0.7 % in Benin to 45.9 % in Namibia. Independent determinants of cervical cancer screening were: older age (40−49 years) adjusted prevalence ratio (aPR) = 1.77 (95 % CI: 1.64, 1.90) compared with younger age (21−29 years), secondary/higher education (aPR = 1.51, 95 CI: 1.28–1.79) compared with no education, health insurance (aPR = 1.53, 95 % CI: 1.44–1.61) compared with no insurance, and highest socioeconomic status (aPR = 1.39, 95 % CI: 1.26–1.52) compared with lowest. Conclusion: The prevalence of cervical cancer screening is substantially low in sub-Saharan Africa countries and shows a high degree of between-country variation. Interventions aimed at increasing the uptake of cervical cancer screening in sub-Saharan Africa are critically needed.
AB - Background: Cervical cancer is the fourth most common cancer among women worldwide, with an estimate of 570,000 new cases and about 311,000 deaths annually. Low-resource countries, including those in sub-Saharan Africa, have the highest-burden with an estimate of 84 % of all cervical cancers. This study examines the prevalence and socio-demographic-economic factors associated with cervical cancer screening in sub-Saharan Africa. Methods: A weighted population-based cross-sectional study using Demographic and Health Surveys data. We used available data on cervical cancer screening between 2011 and 2018 from the Demographic and Health Surveys for five sub-Saharan African countries (Benin, Ivory Coast, Kenya, Namibia, and Zimbabwe). The study population included women of childbearing age, 21–49 years (n = 28,976). We fit a multivariable Poisson regression model to identify independent factors associated with cervical cancer screening. Results: The overall weighted prevalence of cervical cancer screening was 19.0 % (95 % CI: 18.5 %–19.5 %) ranging from 0.7 % in Benin to 45.9 % in Namibia. Independent determinants of cervical cancer screening were: older age (40−49 years) adjusted prevalence ratio (aPR) = 1.77 (95 % CI: 1.64, 1.90) compared with younger age (21−29 years), secondary/higher education (aPR = 1.51, 95 CI: 1.28–1.79) compared with no education, health insurance (aPR = 1.53, 95 % CI: 1.44–1.61) compared with no insurance, and highest socioeconomic status (aPR = 1.39, 95 % CI: 1.26–1.52) compared with lowest. Conclusion: The prevalence of cervical cancer screening is substantially low in sub-Saharan Africa countries and shows a high degree of between-country variation. Interventions aimed at increasing the uptake of cervical cancer screening in sub-Saharan Africa are critically needed.
UR - http://www.scopus.com/inward/record.url?scp=85102787964&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85102787964&partnerID=8YFLogxK
U2 - 10.1016/j.canep.2021.101930
DO - 10.1016/j.canep.2021.101930
M3 - Article
C2 - 33756434
AN - SCOPUS:85102787964
SN - 1877-7821
VL - 72
JO - Cancer Epidemiology
JF - Cancer Epidemiology
M1 - 101930
ER -
